International pharmaceutical conglomerate GSK, or GlaxoSmithKline, has begun the process of reviewing its global media planning and buying business. Australian trade publication AdNews broke the news yesterday, and today a company representative confirmed the review to Adweek but did not provide additional information.
All 6 Major Agency Networks Invited to Pitch for GSK's Global Media Account
The company spent more than $1 billion in the U.S. last year
